Overview

Public BiotechLSD

Biopharmaceutical company developing Lucid-PSYCH for major depressive disorder and Lucid-MS for multiple sclerosis. Focus on neurodegenerative and metabolic disorders.

Visit Website

Toronto, Canada

$95M
Market Cap
2019
Founded
0
Open Roles

Open Positions

No open positions at this time

Clinical Pipeline(1)

Unknown·N/A·LSD

Investigating Lysosomal Storage Diseases in Minority Groups

Lysosomal Storage Disorders
NCT02120235